Copyright Reports & Markets. All rights reserved.

Global Human Microbiome Therapeutics Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Human Microbiome Therapeutics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 FMT
      • 1.4.3 Microbiome Drugs
    • 1.5 Market by Application
      • 1.5.1 Global Human Microbiome Therapeutics Market Share by Application (2014-2025)
      • 1.5.2 C. difficile
      • 1.5.3 Crohn’s Disease
      • 1.5.4 Inflammatory Bowel Disease
      • 1.5.5 Diabetes
      • 1.5.6 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Human Microbiome Therapeutics Market Size
    • 2.2 Human Microbiome Therapeutics Growth Trends by Regions
      • 2.2.1 Human Microbiome Therapeutics Market Size by Regions (2014-2025)
      • 2.2.2 Human Microbiome Therapeutics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Human Microbiome Therapeutics Market Size by Manufacturers
      • 3.1.1 Global Human Microbiome Therapeutics Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Human Microbiome Therapeutics Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Human Microbiome Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Human Microbiome Therapeutics Key Players Head office and Area Served
    • 3.3 Key Players Human Microbiome Therapeutics Product/Solution/Service
    • 3.4 Date of Enter into Human Microbiome Therapeutics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Human Microbiome Therapeutics Market Size by Type (2014-2019)
    • 4.2 Global Human Microbiome Therapeutics Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Human Microbiome Therapeutics Market Size (2014-2019)
    • 5.2 Human Microbiome Therapeutics Key Players in United States
    • 5.3 United States Human Microbiome Therapeutics Market Size by Type
    • 5.4 United States Human Microbiome Therapeutics Market Size by Application

    6 Europe

    • 6.1 Europe Human Microbiome Therapeutics Market Size (2014-2019)
    • 6.2 Human Microbiome Therapeutics Key Players in Europe
    • 6.3 Europe Human Microbiome Therapeutics Market Size by Type
    • 6.4 Europe Human Microbiome Therapeutics Market Size by Application

    7 China

    • 7.1 China Human Microbiome Therapeutics Market Size (2014-2019)
    • 7.2 Human Microbiome Therapeutics Key Players in China
    • 7.3 China Human Microbiome Therapeutics Market Size by Type
    • 7.4 China Human Microbiome Therapeutics Market Size by Application

    8 Japan

    • 8.1 Japan Human Microbiome Therapeutics Market Size (2014-2019)
    • 8.2 Human Microbiome Therapeutics Key Players in Japan
    • 8.3 Japan Human Microbiome Therapeutics Market Size by Type
    • 8.4 Japan Human Microbiome Therapeutics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Human Microbiome Therapeutics Market Size (2014-2019)
    • 9.2 Human Microbiome Therapeutics Key Players in Southeast Asia
    • 9.3 Southeast Asia Human Microbiome Therapeutics Market Size by Type
    • 9.4 Southeast Asia Human Microbiome Therapeutics Market Size by Application

    10 India

    • 10.1 India Human Microbiome Therapeutics Market Size (2014-2019)
    • 10.2 Human Microbiome Therapeutics Key Players in India
    • 10.3 India Human Microbiome Therapeutics Market Size by Type
    • 10.4 India Human Microbiome Therapeutics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Human Microbiome Therapeutics Market Size (2014-2019)
    • 11.2 Human Microbiome Therapeutics Key Players in Central & South America
    • 11.3 Central & South America Human Microbiome Therapeutics Market Size by Type
    • 11.4 Central & South America Human Microbiome Therapeutics Market Size by Application

    12 International Players Profiles

    • 12.1 Enterome Bioscience
      • 12.1.1 Enterome Bioscience Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Human Microbiome Therapeutics Introduction
      • 12.1.4 Enterome Bioscience Revenue in Human Microbiome Therapeutics Business (2014-2019)
      • 12.1.5 Enterome Bioscience Recent Development
    • 12.2 Rebiotix
      • 12.2.1 Rebiotix Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Human Microbiome Therapeutics Introduction
      • 12.2.4 Rebiotix Revenue in Human Microbiome Therapeutics Business (2014-2019)
      • 12.2.5 Rebiotix Recent Development
    • 12.3 Seres Therapeutics
      • 12.3.1 Seres Therapeutics Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Human Microbiome Therapeutics Introduction
      • 12.3.4 Seres Therapeutics Revenue in Human Microbiome Therapeutics Business (2014-2019)
      • 12.3.5 Seres Therapeutics Recent Development
    • 12.4 Vedanta Biosciences
      • 12.4.1 Vedanta Biosciences Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Human Microbiome Therapeutics Introduction
      • 12.4.4 Vedanta Biosciences Revenue in Human Microbiome Therapeutics Business (2014-2019)
      • 12.4.5 Vedanta Biosciences Recent Development
    • 12.5 Bristol-Myers Squibb
      • 12.5.1 Bristol-Myers Squibb Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Human Microbiome Therapeutics Introduction
      • 12.5.4 Bristol-Myers Squibb Revenue in Human Microbiome Therapeutics Business (2014-2019)
      • 12.5.5 Bristol-Myers Squibb Recent Development
    • 12.6 Johnson & Johnson
      • 12.6.1 Johnson & Johnson Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Human Microbiome Therapeutics Introduction
      • 12.6.4 Johnson & Johnson Revenue in Human Microbiome Therapeutics Business (2014-2019)
      • 12.6.5 Johnson & Johnson Recent Development
    • 12.7 Takeda Pharmaceutical
      • 12.7.1 Takeda Pharmaceutical Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Human Microbiome Therapeutics Introduction
      • 12.7.4 Takeda Pharmaceutical Revenue in Human Microbiome Therapeutics Business (2014-2019)
      • 12.7.5 Takeda Pharmaceutical Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Human microbiome has co-evolved with humans for centuries, which includes bacteria, viruses, fungi, Achaeans etc. The human microbiome is now one of the fastest growing areas of biology, and is considered as a newly discovered organ with the potential to have a tremendous impact on human health. Microbiome therapeutics are therapies that are designed to disrupt unhealthy microbial ecological networks and that catalyse the establishment of healthy ones.
      One of the major drivers for this market is side effects of the existing treatments. Various medicines available in the market have several side-effects including minor headaches. These medicines may also impart serious side-effects such as liver or kidney injury, heart problems, and even death. The seriousness of side-effects drives the need for innovative treatment technologies, such as human microbiome therapeutics, that have reduced the negative impact on the human body. The demand for microbiome therapeutics is increasing since it provides treatment sans chemicals.
      The latest trend gaining momentum in the market is growing investments from venture capitalists. Venture capitalists are capitalizing on the need for effective treatment and are offering therapeutic treatment solutions to treat disorders such as autoimmune disorders, infections, and cancer.
      In 2018, the global Human Microbiome Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Human Microbiome Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Human Microbiome Therapeutics development in United States, Europe and China.

      The key players covered in this study
      Enterome Bioscience
      Rebiotix
      Seres Therapeutics
      Vedanta Biosciences
      Bristol-Myers Squibb
      Johnson & Johnson
      Takeda Pharmaceutical
      ...

      Market segment by Type, the product can be split into
      FMT
      Microbiome Drugs

      Market segment by Application, split into
      C. difficile
      Crohn’s Disease
      Inflammatory Bowel Disease
      Diabetes
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Human Microbiome Therapeutics status, future forecast, growth opportunity, key market and key players.
      To present the Human Microbiome Therapeutics development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Human Microbiome Therapeutics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now